Literature DB >> 31996490

Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.

Yasuaki Takeji1, Hiroki Shiomi1, Takeshi Morimoto2, Yutaka Furukawa3, Natsuhiko Ehara3, Yoshihisa Nakagawa4, Takao Kato1, Junichi Tazaki1, Eri Toda Kato1, Hidenori Yaku1, Yusuke Yoshikawa1, Tomohisa Tada5, Michiya Hanyu6, Kazushige Kadota7, Tatsuhiko Komiya8, Kenji Ando9, Takeshi Kimura1.   

Abstract

BACKGROUND: The effect of diabetes mellitus (DM) status on the long-term risk for heart failure (HF) in patients undergoing coronary revascularization has not been adequately evaluated.Methods and 
Results: In this study, 15,231 patients who underwent coronary revascularization in the CREDO-Kyoto Registry Cohort-2 were divided into 2 groups according to DM status (DM group: n=5,999; Non-DM group: n=9,232). The DM group was further divided into 2 groups according to insulin treatment (insulin-treated DM [ITDM]: n=1,353; non-insulin-treated DM [NITDM]: n=4,646). The primary outcome measure was HF hospitalization. The cumulative 5-year incidence of HF hospitalization was significantly higher in the DM than non-DM group (11.0% vs. 6.6%, respectively; log-rank P<0.0001), and in the ITDM than NITDM group (14.6% vs. 10.0%, respectively; log-rank P<0.0001). After adjusting for confounders, the increased risk of HF hospitalization with DM relative to non-DM remained significant (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.30-1.67, P<0.0001), whereas the risk associated with ITDM relative to NITDM was not significant (HR 1.17, 95% CI 0.96-1.43, P=0.12).
CONCLUSIONS: The adjusted long-term risk for HF hospitalization after coronary revascularization was significantly higher in DM than non-DM patients, regardless of revascularization strategy, but did not differ between ITDM and NITDM patients.

Entities:  

Keywords:  Coronary artery disease; Diabetes mellitus; Heart failure

Year:  2020        PMID: 31996490     DOI: 10.1253/circj.CJ-19-0980

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  1 in total

1.  Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy.

Authors:  Shengwei Wang; Hao Cui; Keshan Ji; Changpeng Song; Changwei Ren; Hongchang Guo; Changsheng Zhu; Shuiyun Wang; Yongqiang Lai
Journal:  Cardiovasc Diabetol       Date:  2020-05-13       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.